
By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/DFa1OAP

Novo Nordisk’s problems keeping up US supply of Wegovy for weight-loss is back after a brief hiatus, as the company says starter doses will again be in short supply through September.
Studying newborns in neonatal care, researchers found a nearly identical disease-causing bacterial strain in the gut right before a bloodstream infection was diagnosed.

The anti-amyloid hopeful markedly reduced brain amyloid plaque and significantly slowed cognitive and functional decline in adults with early Alzheimer's disease.